AAIM
American Assets Investment Management Portfolio holdings
AUM
$1.24B
This Quarter Return
-26.17%
1 Year Return
+216.47%
3 Year Return
+316.36%
5 Year Return
+491.45%
10 Year Return
+587.47%
AUM
$467M
AUM Growth
+$467M
(-30%)
Cap. Flow
+$3.43M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
33.3%
Holding
174
New
1
Increased
16
Reduced
3
Closed
4
Top Buys
| 1 |
Gilead Sciences
GILD
|
$3.36M |
| 2 |
IBM
IBM
|
$2.22M |
| 3 |
Bank of America
BAC
|
$1.91M |
| 4 |
Banco Santander
SAN
|
$1.17M |
| 5 |
Viatris
VTRS
|
$746K |
Top Sells
| 1 |
TCO
Taubman Centers Inc.
TCO
|
$4.9M |
| 2 |
iShares MSCI United Kingdom ETF
EWU
|
$2.39M |
| 3 |
BPYU
Brookfield Property REIT Inc. Class A Common Stock
BPYU
|
$943K |
| 4 |
Kohl's
KSS
|
$408K |
| 5 |
Scotiabank
BNS
|
$406K |
Sector Composition
| 1 | Financials | 22.95% |
| 2 | Healthcare | 17.96% |
| 3 | Real Estate | 13.39% |
| 4 | Technology | 11.89% |
| 5 | Energy | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
| $4.45M | 0.95% |
97,230
| – | – |
|
27
Royal Bank of Canada
RY
$205B
| $4.43M | 0.95% |
72,000
| – | – |
|
28
Bristol-Myers Squibb
BMY
$96B
| $4.4M | 0.94% |
79,000
| – | – |
|
|
CONE
29
DELISTED
CyrusOne Inc Common Stock
CONE
| $4.38M | 0.94% |
71,000
| – | – |
|
30
Pfizer
PFE
$141B
| $4.18M | 0.89% |
128,000
| – | – |
|
31
Williams-Sonoma
WSM
$23.1B
| $4.12M | 0.88% |
96,780
| – | – |
|
|
ANSS
32
DELISTED
Ansys
ANSS
| $4.07M | 0.87% |
17,500
| – | – |
|
33
American Electric Power
AEP
$59.4B
| $4M | 0.86% |
50,000
| – | – |
|
34
Toronto Dominion Bank
TD
$128B
| $3.99M | 0.85% |
94,000
| – | – |
|
35
HSBC
HSBC
$224B
| $3.98M | 0.85% |
141,918
-13,000
| -8% | -$364K |
|
36
Capital One
COF
$145B
| $3.97M | 0.85% |
78,670
| – | – |
|
|
37
Gilead Sciences
GILD
$140B
| $3.81M | 0.82% |
51,000
+45,000
| +750% | +$3.36M |
|
38
Pinnacle West Capital
PNW
$10.7B
| $3.79M | 0.81% |
50,000
| – | – |
|
39
Bank of Montreal
BMO
$86.7B
| $3.52M | 0.75% |
70,000
| – | – |
|
40
Oracle
ORCL
$635B
| $3.51M | 0.75% |
72,600
| – | – |
|
41
AbbVie
ABBV
$372B
| $3.51M | 0.75% |
46,000
| – | – |
|
|
COR
42
DELISTED
Coresite Realty Corporation
COR
| $3.48M | 0.74% |
30,000
| – | – |
|
43
Kinder Morgan
KMI
$60B
| $3.24M | 0.69% |
232,900
| – | – |
|
44
Abbott
ABT
$231B
| $3.2M | 0.68% |
40,500
| – | – |
|
45
General Motors
GM
$55.8B
| $3.19M | 0.68% |
153,300
| – | – |
|
46
Mondelez International
MDLZ
$79.5B
| $3.06M | 0.65% |
61,010
| – | – |
|
47
Citigroup
C
$178B
| $2.8M | 0.6% |
66,400
| – | – |
|
|
48
IBM
IBM
$227B
| $2.55M | 0.55% |
23,000
+20,000
| +667% | +$2.22M |
|
49
Biogen
BIIB
$19.4B
| $2.53M | 0.54% |
8,000
| – | – |
|
50
AT&T
T
$209B
| $2.52M | 0.54% |
86,466
| – | – |
|